Cargando…
CD155 promotes radioresistance and malignancy of esophageal cancer by regulating Hippo-YAP pathway
The expression of CD155 has been observed to increase in various human cancers, but its role in the development of esophageal cancer (EC) is unclear. Radiotherapy is one of the primary therapeutic options for EC. However, radioresistance is still a severe issue in EC treatment. In this study, Oncomi...
Autores principales: | Xin, Huixian, Liu, Yuchen, Chen, Pengxiang, Yin, Tianwen, Wang, Meijie, Liu, Tianyu, Wen, Zhihua, Cheng, Yufeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9243211/ https://www.ncbi.nlm.nih.gov/pubmed/35768666 http://dx.doi.org/10.1007/s12672-022-00515-z |
Ejemplares similares
-
SPP1 promotes radiation resistance through JAK2/STAT3 pathway in esophageal carcinoma
por: Wang, Meijie, et al.
Publicado: (2022) -
Thymine DNA glycosylase‐regulated TAZ promotes radioresistance by targeting nonhomologous end joining and tumor progression in esophageal cancer
por: Zhou, Wei, et al.
Publicado: (2020) -
YAP and the Hippo pathway in cholangiocarcinoma
por: Sugihara, Takaaki, et al.
Publicado: (2019) -
Targeting Hippo coactivator YAP1 through BET bromodomain inhibition in esophageal adenocarcinoma
por: Song, Shumei, et al.
Publicado: (2020) -
Hippo-YAP/TAZ signaling in angiogenesis
por: Park, Jeong Ae, et al.
Publicado: (2018)